Clinical Trial Update: TRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial of TRK-100STP for chronic kidney disease-related conditions has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Glomerular Disease
• Nephrosclerosis

Drugs mentioned

• TRK-100STP

Snippet

Sponsor: Toray Industries, Inc | Conditions: Chronic Renal Failure, Glomerular Disease | Phase 2, Phase 3 | Status: COMPLETED